188 related articles for article (PubMed ID: 12725685)
1. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model.
Ward RL
Viral Immunol; 2003; 16(1):17-24. PubMed ID: 12725685
[TBL] [Abstract][Full Text] [Related]
2. Influence of potential protective mechanisms on the development of live rotavirus vaccines.
Ward RL; Clark HF; Offit PA
J Infect Dis; 2010 Sep; 202 Suppl():S72-9. PubMed ID: 20684721
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus vaccines: how they work or don't work.
Ward RL
Expert Rev Mol Med; 2008 Feb; 10():e5. PubMed ID: 18267049
[TBL] [Abstract][Full Text] [Related]
4. Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.
Ward RL; Kirkwood CD; Sander DS; Smith VE; Shao M; Bean JA; Sack DA; Bernstein DI
J Infect Dis; 2006 Dec; 194(12):1729-36. PubMed ID: 17109346
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated human rotavirus vaccine, Rotarix.
Bernstein DI
Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
[TBL] [Abstract][Full Text] [Related]
6. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
Ciarlet M; Schödel F
Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
[TBL] [Abstract][Full Text] [Related]
8. LAP
Rey LM; Gil JÁ; Mateus J; Rodríguez LS; Rondón MA; Ángel J; Franco MA
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292251
[TBL] [Abstract][Full Text] [Related]
9. Update on Rotarix: an oral human rotavirus vaccine.
O'Ryan M; Linhares AC
Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus vaccines: is the second time the charm?
Ward RL
Curr Opin Investig Drugs; 2005 Aug; 6(8):798-803. PubMed ID: 16121686
[TBL] [Abstract][Full Text] [Related]
11. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
Nakagomi T; Nakagomi O
Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of protection against rotavirus infection and disease.
Ward R
Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S57-9. PubMed ID: 19252425
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological studies of rotavirus vaccines.
Vesikari T
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of an ideal rotavirus vaccine.
Reisinger KS; Block SL
Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
[TBL] [Abstract][Full Text] [Related]
15. Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: an overview.
Velasquez DE; Parashar UD; Jiang B
Infect Genet Evol; 2014 Dec; 28():561-71. PubMed ID: 25460825
[TBL] [Abstract][Full Text] [Related]
16. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization.
Hoshino Y; Jones RW; Ross J; Kapikian AZ
Vaccine; 2005 May; 23(29):3791-9. PubMed ID: 15893616
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
[TBL] [Abstract][Full Text] [Related]
18. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
19. Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.
Clark HF; Lawley D; Shrager D; Jean-Guillaume D; Offit PA; Whang SY; Eiden JJ; Bennett PS; Kaplan KM; Shaw AR
Pediatr Infect Dis J; 2004 Mar; 23(3):206-11. PubMed ID: 15014293
[TBL] [Abstract][Full Text] [Related]
20. VP6: A candidate rotavirus vaccine.
Ward RL; McNeal MM
J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
